Joseph E Gilliam
Director; PRESIDENT & COO · 12 filings · Latest: Aug 14, 2026
Caris Life Sciences, Inc.
GLAUKOS Corp
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
GKOS | Joseph E Gilliam | PRESIDENT & COO | Aug 11, 2026 | Sale | $179.74 | 60,000 | $10.8M | 72,588 | |
GKOS | Joseph E Gilliam | PRESIDENT & COO | Aug 11, 2026 | Option Exercise | $52.94 | 60,000 | $3.2M | 132,588 | |
GKOS | Gilliam Joseph E | — | Aug 11, 2026 | Proposed Sale | $179.74 | 60,000 | $10.8M | — | |
GKOS | Joseph E Gilliam | PRESIDENT & COO | May 1, 2026 | Sale | $143.54 | 19,573 | $2.8M | 73,419 | |
GKOS | Gilliam Joseph E | — | May 1, 2026 | Proposed Sale | $143.54 | 19,573 | $2.8M | — | |
GKOS | Joseph E Gilliam | PRESIDENT & COO | Jan 22, 2026 | Sale | $127.68 | 10,498 | $1.3M | 92,366 | |
GKOS | Joseph E Gilliam | PRESIDENT & COO | Jan 22, 2026 | Option Exercise | $55.18 | 10,498 | $579.3K | 102,864 | |
GKOS | Joseph E Gilliam | PRESIDENT & COO | Jan 21, 2026 | Sale | $124.65 | 4,502 | $561.2K | 92,366 | |
GKOS | Joseph E Gilliam | PRESIDENT & COO | Jan 21, 2026 | Option Exercise | $55.18 | 4,502 | $248.4K | 96,868 | |
GKOS | Gilliam Joseph E | — | Jan 22, 2026 | Proposed Sale | $127.68 | 10,498 | $1.3M | — | |
GKOS | Gilliam Joseph E | — | Jan 21, 2026 | Proposed Sale | $124.65 | 4,502 | $561.2K | — | |
GKOS | Gilliam Joseph E | — | Nov 18, 2025 | Proposed Sale | $90.00 | 19,340 | $1.7M | — | |
GKOS | Gilliam Joseph E | — | Dec 20, 2024 | Proposed Sale | $149.85 | 3,657 | $548.0K | — | |
GKOS | Gilliam Joseph E | — | Oct 30, 2024 | Proposed Sale | $138.97 | 2,500 | $347.4K | — |